Senzime AB Uppsala news

“We are delighted to have Kim on the team”, said Laura Piccinini CEO of RMI.  “He brings tremendous wisdom and experience building successful medical device companies.”

Mr. Blickenstaff has served as the Chairman of the board of directors of Tandem Diabetes ($5.23 billion market cap) since March 2020. Mr. Blickenstaff previously served as Executive Chairman of the board of directors since March 2019, and on the board of directors since September 2007. Mr.

Respiratory Motion Inc. (RMI) announced today it has signed a distribution agreement with TrillaMed for the U.S. Veteran Health Administration, Department of Defense and other government-based markets. Per the agreement, TrillaMed will work in conjunction with RMI’s direct field team to distribute the ExSpiron® minute ventilation monitor. ExSpiron is the only non-invasive minute ventilation, tidal volume and respiratory rate monitor available in the market.

Respiratory Motion Inc. (RMI) today announced that C. Raymond Larkin Jr. will act as a Strategic Advisor to the Company.

Mr. Larkin was previously President and Chief Executive Officer of Nellcor Puritan Bennett, Inc., one of the world`s preeminent respiratory products companies. Under Mr. Larkin`s leadership over 15 years, Nellcor grew to nearly $1 billion in revenues through the development and introduction of pulse oximetry into w

Respiratory Motion INC. (RMI) today announced the appointment of Laura Piccinini as Chief Executive Officer effective immediately. Piccinini served on the RMI Board of Directors since the beginning of 2020. She succeeds Dr. Jenny Freeman, CEO since 2012. 

Laura is an executive with an outstanding career in the medical device industry including successful leadership assignments across multiple mar